Skip to content

The HOPE Study – Hypothermia to Optimize Perfusion in ECMO

The HOPE Study – Hypothermia to Optimize Perfusion in ECMO - HOPE

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033506
Enrollment
20
Registered
2024-02-01
Start date
2024-04-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung failure (ARDS)

Interventions

Group 1: Intervention group: Cooling (0.5°C per hour) followed by maintaining core body temperature at 34°C using the "Arctic Sun." Intervention period: Maximum of 5 days from reaching the target tem

Sponsors

Charité - Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Adults of any gender - ARDS according to the Berlin Definition (of any origin) - Intensive care therapy with invasive mechanical ventilation - VV-ECMO with blood flow >4.5 lpm - Deep analgosedation (RASS -5)

Exclusion criteria

Exclusion criteria: - Severe intra-abdominal, thoracic, gastrointestinal, and/or intracerebral - Bleedings - Severe thrombocytopenia ( 8) - Uncontrolled shock of any origin (Norepinephrine > 0.4 µg/kg/min) - Bradycardia <55 bpm - Pregnancy

Design outcomes

Primary

MeasureTime frame
Blood flow within the intervention period

Secondary

MeasureTime frame
ECMO blood flow after rewarming, time on ECMO, revolutions per minute of the ECMO, internal pressures of the ECMO, ECMO gas flow, duration of ventilation/ventilation parameters, proportion of primary extubation versus tracheotomy, extrapulmonary organ dysfunction, radiological progression of infiltrates, thrombotic and bleeding-related complications, transfusion requirements, hemostatic support, discharge from the Intensive Care Unit (ICU), mortality (30 days), hemolysis, coagulation profile, inflammatory markers, liver/kidney function, catecholamine requirements.

Countries

Germany

Contacts

Public ContactJulius Kunz

Charité - Universitätmedizin Berlin

julius-valentin.kunz@charite.de030 450 614636

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026